Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer.

Next Previous
Trial Profile

Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2017

At a glance

  • Drugs Goserelin (Primary) ; Cyclophosphamide
  • Indications Primary ovarian insufficiency
  • Focus Therapeutic Use
  • Acronyms POEMS

    • Most Recent Events

    • 09 Dec 2017 Results of final analysis of the study (five-year follow up) , presented at the 40th Annual San Antonio Breast Cancer Symposium.
    • 10 Jun 2017 Biomarkers information updated
    • 28 Oct 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top